牛皮关节炎:皮肤科医生的综合审查-第二部分:查和管理
Scott A Elman1, Lourdes M Perez-Chada2, April Armstrong3
1Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida.
Journal of the American Academy of Dermatology
|June 10, 2024
概括
牛皮关节炎 (PsA) 是一种常见的牛皮并发症. 早期查和量身定制的治疗,考虑到疾病领域,严重程度和患者因素,对于最佳结果至关重要.
科学领域:
- 风湿病学和皮肤病学
- 免疫炎症性疾病 免疫炎症性疾病
背景情况:
- 牛皮关节炎 (PsA) 影响到三分之一的牛皮患者.
- 牛皮的发病通常在PsA之前,突出了皮肤科医生在早期检测中的作用.
- 早期的PsA诊断和治疗显著改善了患者的结果和生活质量.
研究的目的:
- 审查银病关节炎的查,诊断和治疗策略.
- 讨论 PsA 中的并发症考虑和共同管理.
- 强调基于疾病特征和患者因素的个性化治疗选择.
主要方法:
- 关于牛皮关节炎查和管理的文献综述.
- 对影响PsA治疗选择的因素的分析.
- 讨论PSA护理的多学科方法.
主要成果:
- 皮肤科医生是鉴定牛皮病患者的PsA的关键.
- 治疗决策需要平衡疾病领域,严重程度,并发症和患者偏好.
- 获得药物和保险覆盖是选择治疗的重要因素.
结论:
- 全面的PsA管理需要早期查和诊断.
- 考虑到PsA的多面性质,定制的治疗计划是必不可少的.
- 专家之间有效的共同管理可以改善患者的护理和长期预后.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K


